On February 14, 2025, the U.S. Food and Drug Administration (FDA) delivered a Valentine’s Day gift to patients battling symptomatic…
Browsing: patient care
Date: February 12, 2025FDA Approves Adcetris OverviewThe FDA has approved a new combination therapy for adults with relapsed or refractory…
FDA Approves Mirdametinib for NF1-PN: A New Option for PatientsIntroduction: The FDA has recently approved Mirdametinib (Gomekli) from SpringWorks Therapeutics…
Date: February 8, 2025The U.S. Food and Drug Administration (FDA) has recently granted approval for datopotamab deruxtecan (DLNK), a new…